Brca2tm1.1Brn/Brca2tm1.1Brn
involves: 129P2/OlaHsd * BALB/cJ * FVB/N
|
abnormal embryo development |
J:73028
|
embryonic growth retardation |
J:73028
|
embryonic lethality, complete penetrance |
J:73028
|
Brca2tm1.1Sks/Brca2tm1.1Sks
involves: 129 * C57BL/6J * FVB/N
|
normal
reproductive system phenotype |
J:187434
|
Brca2tm1Arge/Brca2+
involves: 129S/SvEv * C57BL/6
|
normal
neoplasm |
J:40594
|
Brca2tm1Arge/Brca2tm1Arge
involves: 129S/SvEv * C57BL/6
|
abnormal amnion morphology |
J:40594
|
abnormal embryo development |
J:40594
|
abnormal extraembryonic tissue morphology |
J:40594
|
abnormal proamniotic cavity morphology |
J:40594
|
abnormal visceral yolk sac morphology |
J:40594
|
decreased embryo size |
J:40594
|
embryonic lethality, complete penetrance |
J:40594
|
enlarged allantois |
J:40594
|
Brca2tm1Arge/Brca2tm2Arge
involves: 129S/SvEv * C57BL/6
|
no abnormal phenotype detected |
J:70564
|
Brca2tm1Arge/Brca2tm2Arge Waptm1(cre)Arge/Wap+
involves: 129S/SvEv * C57BL/6
|
increased mammary adenocarcinoma incidence |
J:70564
|
Brca2tm1Brd/Brca2+
involves: 129S7/SvEvBrd
|
no abnormal phenotype detected |
J:39764
|
Brca2tm1Brd/Brca2tm1.1Sks
involves: 129 * 129S7/SvEvBrd * C57BL/6J * FVB/N
|
normal
reproductive system phenotype |
J:187434
|
Brca2tm1Brd/Brca2tm1Brd
involves: 129S7/SvEvBrd
|
abnormal developmental patterning |
J:39764
|
abnormal embryonic tissue morphology |
J:39764
|
abnormal extraembryonic tissue morphology |
J:39764
|
prenatal lethality, complete penetrance |
J:39764
|
Brca2tm1Brn/Brca2tm1Brn
involves: 129P2/OlaHsd * FVB/N
|
no abnormal phenotype detected |
J:73028
|
Brca2tm1Brn/Brca2tm1Brn Cd19tm1(cre)Cgn/Cd19+
involves: 129P2/OlaHsd
|
chromosome breakage |
J:197442
|
Brca2tm1Brn/Brca2tm1Brn Tg(Nes-cre)1Kln/0
involves: 129P2/OlaHsd * C57BL/6 * SJL
|
normal
nervous system phenotype |
J:144617
|
Brca2tm1Brn/Brca2tm1Brn Tg(Pbsn-cre)4Prb/0
involves: 129P2/OlaHsd * C57BL/6 * DBA/2
|
abnormal prostate gland physiology |
J:161511
|
increased prostate intraepithelial neoplasia incidence |
J:161511
|
prostate gland hyperplasia |
J:161511
|
Brca2tm1Cam/Brca2tm1Brn Tg(Pdx1-cre)6Tuv/0
involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6 * FVB/N
|
exocrine pancreatic insufficiency |
J:166678
|
premature death |
J:166678
|
Brca2tm1Cam/Brca2tm1Cam
129S/SvEv-Brca2tm1Cam
|
abnormal axial skeleton morphology |
J:46812
|
embryonic growth retardation |
J:46812
|
neonatal lethality, incomplete penetrance |
J:46812
|
postnatal lethality, incomplete penetrance |
J:46812
|
prenatal lethality, incomplete penetrance |
J:46812
|
Brca2tm1Cam/Brca2tm1Cam
involves: 129S/SvEv
|
abnormal mitosis |
J:93261
|
Brca2tm1Cam/Brca2tm1Cam
involves: 129S/SvEv * MF1
|
abnormal axial skeleton morphology |
J:46812
|
absent germ cells |
J:46812
|
embryonic growth retardation |
J:46812
|
embryonic lethality during organogenesis, incomplete penetrance |
J:46812
|
female infertility |
J:46812
|
increased T cell derived lymphoma incidence |
J:46812
|
increased thymus weight |
J:46812
|
male infertility |
J:46812
|
neonatal lethality, incomplete penetrance |
J:46812
|
perinatal lethality, incomplete penetrance |
J:46812
|
postnatal lethality, incomplete penetrance |
J:46812
|
premature death |
J:46812
|
Brca2tm1Cbl/Brca2tm1Cbl
either: (involves: 129S2/SvPas * C57BL/10) or (involves: 129S2/SvPas * C57BL/6 * DBA/2)
|
abnormal double-strand DNA break repair |
J:44386
|
abnormal epidermal layer morphology |
J:44386
|
abnormal epidermis stratum basale morphology |
J:44386
|
abnormal epidermis stratum spinosum morphology |
J:44386
|
abnormal rib morphology |
J:44386
|
abnormal skin morphology |
J:44386
|
abnormal sternum morphology |
J:44386
|
absent epidermis stratum corneum |
J:44386
|
absent ovarian follicles |
J:44386
|
azoospermia |
J:44386
|
decreased birth weight |
J:44386
|
decreased body weight |
J:44386
|
decreased fetal weight |
J:44386
|
decreased fibroblast proliferation |
J:44386
|
fetal growth retardation |
J:44386
|
increased T cell derived lymphoma incidence |
J:44386
|
kinked tail |
J:44386
|
male infertility |
J:44386
|
ovary degeneration |
J:44386
|
postnatal lethality, incomplete penetrance |
J:44386
|
premature death |
J:44386
|
small ovary |
J:44386
|
small testis |
J:44386
|
Brca2tm1Hst/Brca2tm1Hst
involves: 129S7/SvEvBrd * C57BL/6
|
decreased tumor latency |
J:82434
|
increased carcinoma incidence |
J:82434
|
increased lymphoma incidence |
J:82434
|
premature death |
J:82434
|
sepsis |
J:82434
|
Brca2tm1Hst/Brca2tm2Hst
involves: 129S7/SvEvBrd * C57BL/6
|
chromosomal instability |
J:82434
|
early cellular replicative senescence |
J:82434
|
Brca2tm1Kamc/Brca2tm1Kamc
involves: 129P2/OlaHsd
|
small testis |
J:268570
|
Brca2tm1Kamc/Brca2tm1Kamc
involves: 129P2/OlaHsd * BALB/c
|
abnormal chromosome morphology |
J:144998
|
abnormal DNA repair |
J:144998
|
abnormal hematopoietic system morphology/development |
J:144998
|
decreased body weight |
J:144998
|
decreased bone marrow cell number |
J:144998
|
decreased common myeloid progenitor cell number |
J:144998
|
impaired hematopoiesis |
J:144998
|
increased mortality induced by ionizing radiation |
J:144998
|
increased sensitivity to induced cell death |
J:144998
|
spleen hypoplasia |
J:144998
|
Brca2tm1Kamc/Brca2tm1Kamc
involves: 129P2/OlaHsd * C57BL/6N
|
abnormal branching of the mammary ductal tree |
J:75026
|
decreased survivor rate |
J:75026,
J:109193
|
increased tumor incidence |
J:75026
|
lethality throughout fetal growth and development, incomplete penetrance |
J:75026
|
normal
neoplasm |
J:109193
|
normal
reproductive system phenotype |
J:75026
|
Brca2tm1Mak/Brca2tm2Mak Tg(Lck-cre)548Jxm/0
involves: 129P2/OlaHsd * C57BL/6 * CBA
|
abnormal chromosome morphology |
J:79697
|
aneuploidy |
J:79697
|
normal
cellular phenotype |
J:79697
|
normal
immune system phenotype |
J:79697
|
increased T cell apoptosis |
J:79697
|
normal
neoplasm |
J:79697
|
Brca2tm1Mbn/Brca2+
B6.Cg-Brca2tm1Mbn ApcMin
|
adrenal gland hyperplasia |
J:67445
|
normal
growth/size/body region phenotype |
J:67445
|
increased mammary gland tumor incidence |
J:67445
|
normal
reproductive system phenotype |
J:67445
|
Brca2tm1Mbn/Brca2+
involves: 129P2/OlaHsd * 129S/SvEv
|
abnormal motor capabilities/coordination/movement |
J:74077
|
Brca2tm1Mbn/Brca2tm1Mbn
C.129P2-Brca2tm1Mbn
|
embryonic growth retardation |
J:74077
|
embryonic lethality during organogenesis, complete penetrance |
J:74077
|
open neural tube |
J:74077
|
Brca2tm1Mbn/Brca2tm1Mbn
involves: 129P2/OlaHsd * 129S/SvEv
|
embryonic lethality between somite formation and embryo turning, complete penetrance |
J:74077
|
Brca2tm1Mhun/Brca2+
involves: 129S7/SvEvBrd * C57BL/6J
|
abnormal cell physiology |
J:89083
|
decreased incidence of tumors by chemical induction |
J:89083
|
decreased tumor incidence |
J:89083
|
increased apoptosis |
J:89083
|
Brca2tm1Mhun/Brca2tm1Mhun
involves: 129S7/SvEvBrd * C57BL/6J
|
embryonic lethality during organogenesis, complete penetrance |
J:89083
|
Brca2tm2.1Sks/Brca2tm1Brd
B6.Cg-Brca2tm1Brd Brca2tm2.1Sks
|
abnormal branching of the mammary ductal tree |
J:323630
|
normal
behavior/neurological phenotype |
J:323630
|
decreased birth body size |
J:323630
|
decreased birth weight |
J:323630
|
decreased body size |
J:323630
|
decreased body weight |
J:323630
|
decreased embryo size |
J:323630
|
decreased mammary duct terminal end bud number |
J:323630
|
normal
embryo phenotype |
J:323630
|
normal
growth/size/body region phenotype |
J:323630
|
increased mortality induced by ionizing radiation |
J:323630
|
normal
neoplasm |
J:323630
|
premature death |
J:323630
|
prenatal lethality, incomplete penetrance |
J:323630
|
normal
reproductive system phenotype |
J:323630
|
Brca2tm2.1Sks/Brca2tm2.1Sks
Not Specified
|
decreased embryo size |
J:323630
|
normal
embryo phenotype |
J:323630
|
normal
homeostasis/metabolism phenotype |
J:323630
|
normal
mortality/aging |
J:323630
|
normal
neoplasm |
J:323630
|
prenatal lethality, incomplete penetrance |
J:323630
|
normal
reproductive system phenotype |
J:323630
|
Brca2tm2Arge/Brca2tm2Arge Waptm1(cre)Arge/Waptm1(cre)Arge
involves: 129S1/Sv * C57BL/6
|
increased mammary adenocarcinoma incidence |
J:70564
|
Brca2tm2Hst/Brca2tm2Hst
involves: 129S7/SvEvBrd * C57BL/6
|
embryonic lethality, complete penetrance |
J:82434
|
Brca2tm2Mak/Brca2tm2Mak
involves: 129P2/OlaHsd * C57BL/6
|
no abnormal phenotype detected |
J:79697
|